Concepedia

Nicolas Azzopardi

NA

Statistics

Publications

18

Citations

766

H-Index

16

Active since

2009

Affiliations

Université de Tours(Current)

Centre Hospitalier Universitaire de Tours

Centre National de la Recherche Scientifique

Inserm

Clinical Investigation Center Plurithematic Tours

Nicolas Azzopardi is an author at Université de Tours specializing in pharmacy, pharmacokinetics of monoclonal antibodies, and oncology.

ORCID

Publications per year

2009–2023

18

Publications

18

Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system

Laurent Guilleminault, Nicolas Azzopardi, Christophe Arnoult et al. · Journal of Controlled Release · 2014 · 111 citations · Full text

, , +16

Cetuximab Pharmacokinetics Influences Progression-Free Survival of Metastatic Colorectal Cancer Patients

Nicolas Azzopardi, Thierry Lecomte, David Ternant et al. · Clinical Cancer Research · 2011 · 98 citations

, , +17

The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors

A. Maillet, Laurent Guilleminault, Étienne Lemarié et al. · Pharmaceutical Research · 2011 · 74 citations

, , +14

Influence of<i>FCGRT</i>gene polymorphisms on pharmacokinetics of therapeutic antibodies

Christophe Passot, Nicolas Azzopardi, Sylvaine Renault et al. · mAbs · 2013 · 65 citations · Full text

, , +16

An Enzyme-Linked Immunosorbent Assay for Therapeutic Drug Monitoring of Cetuximab

Nicolas Cézé, David Ternant, Danielle Degenne et al. · Therapeutic Drug Monitoring · 2009 · 62 citations

, , +14

1–5 of 18